Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Penile Squamous Cell Carcinoma (PSCC) 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Urothelial Cancer 1 Melanoma 1 Lymphatic Metastasis 1 Gestational Trophoblastic Neoplasias (GTN) 1 Endometrial Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 10 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Tumor 1

Interventions

Injections 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 Cyclophosphamide 3 toripalimab 2 fludarabine 2 Nivolumab 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 trametinib 1 tislelizumab 1 temsirolimus 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 enzalutamide 1 donafenib 1 disitamab vedotin 1 dabrafenib 1 avelumab 1 atezolizumab 1 anlotinib 1 WW Domain-Containing Oxidoreductase 1 Valproic Acid 1 Ultrasonography, Doppler 1 Ultrasonography 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03707808 2025-01-20

myDAvIpNi

Universitair Ziekenhuis Brussel

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡